Condition: Mastocytosis · Bones · Sponsor: Medical University of Lublin
Mastocytosis is very rare and highly heterogeneous group of disorders, characterized by the accumulation of clonal mast cells which can infiltrate several organs and tissues. Bones are the most frequent localization of systemic mastocytosis. The aim of our research was to explain the potential role of sclerostin in the pathogenesis of bone disease in mastocytosis.
This description comes directly from the study's public registry record.
Aneta Szudy-Szczyrek, MD., PhD. · +48815345468 · aneta.szudy-szczyrek@umlub.pl
Always discuss trial participation with your own doctor first.
| Department of Hematooncology and Bone Marrow Transplantation | Lublin, Lublin Voivodeship, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06440148